Candriam S.C.A. Charles River Laboratories International, Inc. Transaction History

Candriam S.C.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $438,852 - $594,437	-2,287 Reduced 44.38%	2,866 $578,000
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $9.13 Million - $11.6 Million	-46,301 Reduced 89.99%	5,153 $1.12 Million
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $429,281 - $589,520	-2,353 Reduced 4.37%	51,454 $10.1 Million
Q2 2022 Aug 03, 2022	SELL	$204.13 - $302.4 $2.8 Million - $4.15 Million	-13,723 Reduced 20.32%	53,807 $11.5 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $16.1 Million - $22.8 Million	-62,879 Reduced 48.22%	67,530 $19.2 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $31.7 Million - $40.5 Million	-90,296 Reduced 40.91%	130,409 $49.1 Million
Q3 2021 Nov 09, 2021	SELL	$372.64 - $458.3 $6.5 Million - $7.99 Million	-17,442 Reduced 7.32%	220,705 $91.1 Million
Q2 2021 Jul 20, 2021	BUY	$294.17 - $371.65 $49.4 Million - $62.4 Million	167,967 Added 239.34%	238,147 $88.1 Million
Q1 2021 Apr 29, 2021	BUY	$249.67 - $299.48 $2,746 - $3,294	11 Added 0.02%	70,180 $16.8 Million
Q4 2020 Jan 22, 2021	BUY	$222.0 - $252.62 $5.84 Million - $6.65 Million	26,323 Added 60.04%	70,169 $17.5 Million
Q3 2020 Oct 19, 2020	BUY	$175.56 - $226.45 $7.7 Million - $9.93 Million	43,846 New	43,846 $9.93 Million

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.